FDA Warning Letter — Glenmark Pharmaceuticals Limited
The FDA took a Warning Letter action against Glenmark Pharmaceuticals Limited on Oct 3, 2019 (Solan, India). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Glenmark Pharmaceuticals Limited
- Date
- Oct 3, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Center
- CDER
- Location
- Solan (India)